anti-VEGF-D� antibody product blog
Tags: Antibody; VEGF-D; Monoclonal Antibody; anti-VEGF-D� antibody;
The VEGF-D� vegfd (Catalog #MBS2544031) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Rabbit anti Human�VEGF-D� Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s VEGF-D� can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA).ELISA: 0.1-0.2 mug/mL. This antibody can be used at 0.1-0.2 mug/mL with the appropriate secondary reagents to detect Human VEGF-D. The detection limit for Human VEGF-D is approximately 0.0049 ng/well. Researchers should empirically determine the suitability of the VEGF-D� vegfd for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The VEGF-D� vegfd product has the following accession number(s) (GI #4758378). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Vascular endothelial growth factor D (VEGF-D), also known as C-fos induced growth factor (FIGF), belongs to the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. FIGF protein is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. FIGF protein is secreted as a non-covelent homodimer in an antiparallel fashion. Human FIGF protein is expressed in adult lung, heart, muscle, and small intestine, and is most abundantly expressed in fetal lungs and skin. FIGF protein is structurally and functionally similar to VEGF-C. Therefore, FIGF protein binds and activates VEGFR-2 (Flk1) and VEGFR-3 (Flt4) receptors, and may particularly be involved in cancers, such as breast cancer, epithelial ovarian carcinoma and so on.
Immunogen: Recombinant Human VEGF-D protein
Buffer: This antibody was obtained from a rabbit immunized with purified, recombinant Human VEGF-D (rh VEGF-D; NP_004460.1; Phe 93-Ser 201). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing VEGF-D� are readily searchable from our website. Different antibodies against the same target such as VEGF-D� may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Breast Neoplasms, Cell Transformation, Neoplastic, Disease Models, Animal, Inflammation, Kidney Diseases, Liver Diseases, Lung Neoplasms, Lymphangioleiomyomatosis, Necrosis, Neoplasms, Experimental are some of the diseases may be linked to Rabbit anti Human�VEGF-D� Monoclonal Antibody. VEGF-D� also interacts with the following gene(s): ALB, FIGF, FLT1, FLT4, IGF1, KDR, TEK, TIMP1, VEGFA, VWF. The following patways have been known to be associated with this gene.